This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A PET study has revealed that women over the age of 70 who took menopausal hormone therapy (HT) more than a decade before have faster brain tau accumulation -- a key indicator of Alzheimers disease. The findings may inform [Alzheimers disease] risk discussions relating to womens reproductive health and treatment, the group wrote.
The imaging agent fills an unmet need to identify small lesions, which could allow earlier diagnosis of the disease, noted lead author Brian Shuch, MD, of the University of California, Los Angeles, and colleagues. Images available under Creative Commons license (CC BY 4.0 Images available under Creative Commons license (CC BY 4.0
AI imaging firm Brainomix has entered into a partnership with German pharmaceutical company Boehringer Ingelheim to improve the care of U.S. patients with fibrosing lung disease. Through the partnership, Brainomix will deploy its e-Lung software, which has 510(k) clearance from the U.S.
announced a research collaboration agreement with the Alzheimer’s Disease Neuroimaging Initiative 4, ADNI4, on the use of Meilleur’s [F-18]NAV-4694, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status amyloid plaque in the brain.
Telix Pharmaceuticals has selected Cardinal Health to distribute its PET agent TLX250-CDx (Zircaix) for imaging kidney cancer in the U.S., In a recent phase III trial , the radiotracer was shown to be safe and effective for identifying small lesions, which could allow for earlier diagnosis of the disease. the company noted.
Enigma Biomedical Group USA (EBG-USA) has signed an exclusive agreement to commercialize AbbVie’s tau PET imaging biomarkers for use in patients with suspected neurodegenerative disease. Tau ligands labeled with F-18 radioisotopes are used as radiotracers during PET imaging to visualize this pathology.
Clarity Pharmaceuticals has secured fast-track designation from the U.S. The classification builds on Clarity's earlier receipt of fast-track designation for its PET diagnostic imaging agent Cu-64 SAR-bisPSMA for identifying patients with the disease.
Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.
For many, machine learning's potential is more than just talk; the power of well-trained, image-augmented AI has already been demonstrated as a useful tool for quality control, disease tracking, tumor segmentation, and making prognosis predictions.
Vienna-based Image Biopsy Lab is debuting Flamingo, the latest module of its IB Lab Zoo automated analysis musculoskeletal software platform. IB Lab Flamingo analyzes CT images of the upper extremities and the spine for the detection and classification of osteoporotic fractures of the spine.
The scanner also comes with True Enhance DL, an AI-based application that generates deep learning-based monochromatic-like images from a single-energy x-ray acquisition. GEHC also pointed to upgrades for its Revolution Apex scanner, including ECG-less Cardiac for acquiring cardiac images without the need for an ECG signal or trace.
Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.
Not long after the first United Theranostics center emerged from Advanced Molecular Imaging and Therapy, just prior to the pandemic era in Glen Burnie, MD, the practice is quickly evolving into a more concerted effort to design theranostics centers from the East Coast to the Southeast and Southwest, and subsequently throughout the U.S.,
Imaging and radiology centers are among the least affected hospital services in Ukraine since the beginning of the Russian invasion in 2022, a study published May 17 in JAMA Health Forum found. The researchers reported that imaging and radiology centers were among the least affected services since the start of the war.
The scientists will then use artificial intelligence and machine learning to analyze the image data, linked to relevant patient data on demographics, treatment history and pre-existing conditions. tim.hodson Tue, 01/21/2025 - 13:17 Jan.
is the only FDA approved FES PET imaging agent. Cerianna is indicated for use with PET imaging for the detection of ER+ lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer. GE HealthCare’s Cerianna , available in the U.S., In the U.S., J Nucl Med. 2011;52(10):1541-1549 / Currin, et al.
The company reports that the major update delivers the industry’s first multi-AI workflows, which simultaneously display results from more than one application in Proscia’s precision medicine AI portfolio on the same image. Today’s news comes on the heels of a series of announcements from Proscia.
The ubiquitous expression of FAP in cancer-associated fibroblasts across nearly all epithelial-derived cancers paired with the low abundance in normal tissues, makes it a unique target to exploit for tumor imaging for a wide variety of cancers such as breast, pancreatic, lung and stomach cancer.
milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based
GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.
a clinical-stage biotech developing groundbreaking secretome therapeutics for age and disease-related immune dysfunction, has announced a partnership with Springbok Analytics , a life sciences muscle analytics company. christine.book Thu, 07/25/2024 - 12:44 July 25, 2024 — Immunis, Inc. ,
announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. This includes MIMneuro , which offers quantification solutions for dopamine transporter imaging and amyloid imaging.
The ubiquitous expression of FAP in cancer-associated fibroblasts across nearly all epithelial-derived cancers paired with the low abundance in normal tissues, makes it a unique target to exploit for tumor imaging for a wide variety of cancers such as breast, pancreatic, lung and stomach cancer.
a pioneer in AI -driven predictive analytics using multi-modal data including text, signal, and image (US Patent No.11263749) milla1cf Mon, 11/20/2023 - 12:27 November 20, 2023 — InMed.AI (InMed Prognostics Inc.), In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics.
produced, non-uranium based Mo-99 for use in diagnostic imaging. These capabilities will help them develop and deliver products with the potential to improve care for even more patients with serious disease. “In In parallel with these initiatives, NorthStar’s imaging portfolio continues to advance,” Mr. Merrick further added.
The statement further noted that digital pathology is modernizing the microscope-based practice, driving a shift to high-resolution images that each contain over 1 billion pixels telling the story of a patient’s disease.
The agents affected include some of the most widely used contrast products in medical imaging. The recommendation was issued by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), the primary body in the European Union responsible for regulating pharmaceuticals.
Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images and helps to drive confidence and efficiency gains. It can also streamline collaboration, broadening access to expertise. Reference: 1. NHS England (2017).
milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., Disclaimer: OmnifyXR is intended to be used adjunctively to standard of care imaging.
i] In a July 19 statement announcing the published research, Bracco Imaging added that it has launched gadopiclenol as VUEWAY (gadopiclenol) solution for injection and VUEWAY (gadopiclenol) Pharmacy Bulk Package, following the 2022 approval of gadopiclenol by the United States Food and Drug Administration (U.S. [ii],
Different types of medical imaging response criteria: morphological measures In oncology clinical trials, therapy is generally assessed using imaging response criteria involving imaging biomarkers. They can be qualitative or quantitative. The basis of RECIST1.1
Scott Claunch , President of TerraPower Isotopes, added: "Consistent with TerraPower’s vision of developing innovative solutions to help fight disease using nuclear science, TerraPower Isotopes is thrilled to secure this collaboration with PanTera.
million images. The team will use artificial intelligence and machine learning to analyze the image data alongside linked health records such as demographics and treatment history, without patients being identifiable, to find patterns that could indicate a person’s risk of developing dementia.
The rise of precision medicine is putting new pressures on diagnostic laboratories to tap into their pathology data, as whole slide images are among the best representations of disease. Concentriq is used by 14 of the top 20 pharmaceutical companies and major diagnostic laboratories worldwide.
milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc.
Also, the new online pharmaceutical retail industry is gradually penetrating the market. The present day radiologists reading MRI, CT-Scan, X-Ray, PET-CT scan are burdened with large volumes of images to be interpreted. MRI scans offer many applications in the disease diagnosis like neuroscans, liver scans and cardiac.
For those unfamiliar with steatotic liver disease, this is important because Rezdiffra is the first approved treatment for MASH, which if left untreated can progress to cirrhosis, require liver transplantation, and potentially cause death. Rajarshi Banerjee, MD, PhD.
Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. It certainly doesn't help matters that the disease has been linked to gadolinium-based contrast agents, a ubiquitous tool in the MR armamentarium. How are imaging experts and others handling NSF?
Ac-225 with Curadh is an important step in helping to provide molecularly targeted radiation therapies for patients with cancer, and we look forward to working with them going forward.” “Molecularly targeted radiation is an exciting new field in oncology enabling us to deliver ‘systemic radiotherapy’ to patients with metastatic disease.
Nucleus will use NorthStar’s Ac-225 for their customers’ radioligand pharmaceutical programs. Such contaminants pose regulatory and waste management challenges for pharmaceutical companies, hospitals, and health systems. Under terms of the agreement, NorthStar will supply its high purity, non-carrier added (n.c.a.) Ac-225 to Nucleus.
head of the Division of Infectious Disease and Global Public Health at UC San Diego School of Medicine , co-director of the university’s Altman Clinical and Translational Research Institute , and study senior author. Ayers , Ph.D.,
A regular supply chain of affordable medicines and pharmaceuticals is also not in place because of limited indigenous production of drugs and scarce medical research facilities. According to the World Health Organization (WHO), Africa carries 25% of the world’s disease burden but its share of global health expenditures is less than 1%.
The tool also successfully assessed the likelihood of additional conditions accompanying a primary disease (comorbidity index) as well as the chances of an insurance denial. Oermann is a consultant for Sofinnova Partners , a venture-capital firm that specializes in the development of biotechnologies, sustainability, and pharmaceuticals.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content